STOCK TITAN
  1. Home
  2. Sec-filings
  3. OVID
  4. [144] Ovid Therapeutics Inc. SEC Filing

Ovid Therapeutics (OVID) insider prepares new stock sale after recent August trades

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Ovid Therapeutics Inc. (symbol OVID) has an affiliated stockholder, Jeffrey A. Rona, filing a notice of proposed sale under Rule 144 for up to 325,000 shares of common stock, expected around 08/24/2026, to be effected through Morgan Stanley following a stock option exercise for cash.

The common stock has 195,297,857 shares outstanding. In the prior three months, Jeffrey A. Rona reported Rule 144 sales of common stock on 08/17/2026, 08/18/2026, and 08/19/2026 at disclosed share amounts and dollar values.

Positive

  • None.

Negative

  • None.
Shares to be sold under Rule 144 325,000 shares Proposed sale of Ovid Therapeutics Inc. common stock around 08/24/2026
Aggregate market value of proposed sale $910,000 Aggregate market value for 325,000 shares covered by the Rule 144 notice
Shares outstanding 195,297,857 shares Ovid Therapeutics Inc. common stock shares outstanding as stated in the filing
Sale on 08/17/2026 52,532 shares; $149,978.86 Jeffrey A. Rona sale of Ovid common stock during past three months
Sale on 08/18/2026 60,000 shares; $169,800.00 Jeffrey A. Rona sale of Ovid common stock during past three months
Sale on 08/19/2026 37,468 shares; $108,657.20 Jeffrey A. Rona sale of Ovid common stock during past three months
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Affiliated Stockholder financial
"Affiliated Stockholder 144: Securities Information"
Stock Option Exercise financial
"Common Stock | 08/24/2026 | Stock Option Exercise | Issuer"
A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

FAQ

What does the Form 144 filing disclose for OVID Therapeutics Inc. (OVID)?
It discloses that Jeffrey A. Rona, an affiliated stockholder, has filed a Rule 144 notice to potentially sell up to 325,000 shares of Ovid Therapeutics Inc. common stock, expected around 08/24/2026, in connection with a stock option exercise for cash through Morgan Stanley.

How many OVID shares are proposed to be sold under this Rule 144 notice?
The notice covers a proposed sale of up to 325,000 shares of Ovid Therapeutics Inc. common stock. These shares are expected to be sold in connection with a stock option exercise for cash on or about 08/24/2026.

What is the reported aggregate market value of the OVID shares to be sold?
The filing reports an aggregate market value of $910,000 for the 325,000 shares of Ovid Therapeutics Inc. common stock covered by the proposed Rule 144 sale, with an indicated approximate sale date of 08/24/2026.

How many OVID shares are outstanding according to this filing?
The filing states that there are 195,297,857 shares of Ovid Therapeutics Inc. common stock outstanding. This figure provides context for the 325,000 shares covered by the proposed Rule 144 sale; it is a baseline figure, not the amount being sold.

What OVID stock sales has Jeffrey A. Rona reported in the past three months?
The filing lists three prior sales of Ovid common stock: 52,532 shares for $149,978.86 on 08/17/2026, 60,000 shares for $169,800.00 on 08/18/2026, and 37,468 shares for $108,657.20 on 08/19/2026.

Through which broker is the proposed OVID Rule 144 sale expected to be executed?
The proposed sale of up to 325,000 shares of Ovid Therapeutics Inc. common stock is listed as being through Morgan Stanley, with the broker identified at its 1585 Broadway, New York address in the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR